Lam Research Corporation LRCX NDXSPXR3KAITECH
Company Overview
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition, which support copper damascene manufacturing; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced chemical vapor deposition (CVD) products. It also provides Akara, a conductor etch system designed to enhance etch precision, selectivity, and defect control; Argos, Prevos, and Selis, which are selective etch systems used in the fabrication of advanced logic and memory devices that require precise control at nanoscale dimensions; Flex for dielectric etch applications; Vantex, a dielectric etch system that provides RF technology and repeatable wafer-to-wafer performance enabled by Equipment Intelligence solutions; Kiyo for conductor etch applications; Syndion for deep silicon etch; and Versys metal products for metal etch processes. In addition, the company offers Coronus bevel clean products to enhance die yield and Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications. Further, it provides Reliant deposition, etch, and clean products; Sense.i platform products; and customer service, spares, and upgrades. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Why Investors Should Care
Generates a return on equity of 65.1%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 39.9%.
Maintains a net profit margin of 31.3%.
Carries low leverage with a debt-to-equity ratio of 0.33.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Jun 2026 Revenue of $23.23B (+26.0% YoY); net profit $7.27B.
- Trailing 12 Months Year-on-year growth — revenue +30.0%, earnings +34.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 2.3%, profit CAGR 5.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 2.29% |
| 1 Year: | 30.00% |
Compounded Profit Growth
| 5 Years: | 5.18% |
| 1 Year: | 34.80% |
Stock Price Performance
| 1 Year: | +116.76% |
| 6 Months: | -13.92% |
| 3 Months: | -21.01% |
| 1 Month: | -25.09% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Etch/deposition tools for HBM + advanced logic.
- Etch & deposition for AI memory/logic Lam Research's etch and deposition tools are critical to making 3D NAND, DRAM/HBM and advanced logic that power AI.
- Advanced packaging & gate-all-around Lam is positioned for the GAA-transistor and advanced-packaging transitions that AI chips require.
- AI in fab equipment Machine-learning-driven process optimisation improves customer yields.
- Key AI-chip equipment supplier with strong ~31% net margins and ROE ~67%.
- HBM/DRAM demand for AI is a direct tailwind for Lam's etch/deposition tools.
- Strong free cash flow funds buybacks and dividends.
- Memory-capex cyclicality and China exposure are the main risks.
Curated from public filings and analyst commentary; figures are illustrative.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 65.1%.
- Healthy ROCE of 39.9%.
- Excellent profit margin of 31.3%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 46.8% below its 52-week high.
- RSI at 25 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LRCX Lam Research Corporation NDXSPXR3KAITECH | 230.10 | 39.95 | $287.93B | 0.49% | 39.93% | 65.07% | 2.29% | 5.18% |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 210.96 | 26.64 | $5.09T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 347.72 | 39.88 | $5.07T | 0.32% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 524.51 | 29.19 | $3.89T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 418.51 | 31.19 | $2.17T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 321.68 | 41.08 | $1.54T | 0.72% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 877.55 | 19.82 | $991.10B | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 516.79 | 131.83 | $843.65B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,571.80 | 51.02 | $603.73B | 0.50% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.48B | 2.58B | 2.89B | 2.33B | 2.52B | 2.44B | 2.17B | 2.58B | 2.50B | 3.18B | 3.46B | 3.85B | 4.30B | 4.23B | 4.06B | 5.07B | 5.28B | 3.87B | 3.48B | 3.76B | 3.79B | 4.17B | 4.38B | 4.72B | 5.32B | 5.34B | 5.84B |
| Gross Profit | 339.83M | 431.86M | 487.79M | 530.80M | 505.54M | 536.66M | 600.60M | 722.36M | 626.51M | 571.26M | 716.20M | 846.80M | 971.40M | 1.15B | 1.21B | 1.33B | 1.06B | 1.15B | 1.07B | 981.71M | 1.18B | 1.17B | 1.51B | 1.60B | 1.78B | 1.98B | 1.98B | 1.82B | 2.34B | 2.38B | 1.61B | 1.65B | 1.76B | 1.80B | 2.00B | 2.07B | 2.31B | 2.68B | 2.65B | 2.91B |
| Operating Income | 10.82M | 105.41M | 164.47M | 191.94M | 168.30M | 188.74M | 239.97M | 335.43M | 238.83M | 190.75M | 315.95M | 439.83M | 538.42M | 693.22M | 737.37M | 827.51M | 591.75M | 690.38M | 565.52M | 537.46M | 686.51M | 694.11M | 961.06M | 1.01B | 1.20B | 1.37B | 1.34B | 1.19B | 1.70B | 1.68B | 942.25M | 1.02B | 1.06B | 1.06B | 1.26B | 1.33B | 1.56B | 1.83B | 1.81B | 2.05B |
| Net Income | 19.00M | 85.51M | 148.99M | 164.40M | 141.08M | 176.94M | 206.28M | 288.68M | 222.98M | 143.45M | 263.83M | 332.79M | 574.71M | 590.69M | -9.96M | 778.80M | 533.36M | 568.86M | 547.39M | 465.79M | 514.51M | 574.78M | 823.45M | 869.23M | 1.07B | 1.18B | 1.19B | 1.02B | 1.43B | 1.47B | 814.01M | 887.40M | 954.27M | 965.83M | 1.12B | 1.19B | 1.33B | 1.57B | 1.59B | 1.83B |
| Diluted EPS | 0.11 | 0.50 | 0.87 | 0.96 | 0.80 | 1.00 | 1.16 | 1.66 | 1.28 | 0.82 | 1.47 | 1.81 | 3.10 | 3.21 | -0.06 | 4.33 | 3.23 | 3.51 | 3.47 | 3.09 | 3.43 | 3.88 | 5.59 | 5.96 | 7.41 | 8.27 | 8.44 | 7.30 | 10.39 | 10.77 | 6.01 | 0.67 | 0.72 | 0.73 | 0.86 | 0.92 | 1.03 | 1.24 | 1.26 | 1.45 |
| R&D Expense | 174.21M | 170.57M | 174.48M | 185.98M | 188.93M | 196.77M | 217.87M | 234.21M | 220.75M | 221.49M | 235.24M | 246.80M | 265.99M | 275.08M | 281.31M | 305.41M | 291.67M | 285.56M | 318.51M | 286.83M | 318.86M | 307.91M | 355.37M | 375.17M | 381.12M | 382.33M | 403.64M | 407.12M | 433.38M | 462.38M | 429.45M | 422.63M | 469.71M | 512.27M | 495.36M | 494.95M | 525.90M | 576.45M | 573.30M | 583.20M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.12B | 2.13B | 3.24B | 2.67B | 3.60B | 4.61B | 5.26B | 5.89B | 8.01B | 11.08B | 9.65B | 10.04B | 14.63B | 17.23B | 17.43B | 14.91B | 18.44B | 23.23B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.36B | 9.65B | 7.85B | 9.46B | - |
| Gross Profit | 388.73M | 969.93M | 1.50B | 1.08B | 1.40B | 2.01B | 2.28B | 2.62B | 3.60B | 5.17B | 4.36B | 4.61B | 6.81B | 7.87B | 7.78B | 7.05B | 8.98B | 11.73B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.49B | 2.56B | 2.77B | 3.08B | - |
| Operating Income | -281.24M | 425.41M | 804.28M | 237.73M | 118.07M | 677.67M | 788.04M | 1.07B | 1.90B | 3.21B | 2.46B | 2.67B | 4.48B | 5.38B | 5.22B | 4.28B | 5.90B | 8.20B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.71B | 5.64B | 4.91B | 6.52B | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 184.76M | 186.46M | 185.24M | 178.20M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.19B | 5.11B | 4.36B | 5.96B | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 587.83M | 598.28M | 532.45M | 599.91M | - |
| Net Income | -302.15M | 346.67M | 723.75M | 168.72M | 113.88M | 632.29M | 655.58M | 914.05M | 1.70B | 2.38B | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Diluted EPS | -2.41 | 2.71 | 5.79 | 1.35 | 0.66 | 3.62 | 3.70 | 5.22 | 9.24 | 13.17 | 13.70 | 15.10 | 26.90 | 3.27 | 3.32 | 2.90 | 4.15 | 5.76 |
| R&D Expense | 288.27M | 320.86M | 373.29M | 444.56M | 683.69M | 716.47M | 825.24M | 913.71M | 1.03B | 1.19B | 1.19B | 1.25B | 1.49B | 1.60B | 1.73B | 1.90B | 2.10B | 2.38B |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2008 | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.49B | 4.05B | 8.00B | 7.25B | 7.99B | 9.36B | 12.26B | 12.12B | 12.48B | 12.00B | 14.56B | 15.89B | 17.20B | 18.78B | 18.74B | 21.35B | 23.53B |
| Total Equity | 1.78B | 1.45B | 1.77B | 2.47B | 5.13B | 4.49B | 5.03B | 5.10B | 5.89B | 6.82B | 6.50B | 4.67B | 5.17B | 6.03B | 6.28B | 8.21B | 8.54B | 9.86B | 12.47B |
| Cash & Equivalents | 732.54M | 374.17M | 545.77M | 1.49B | 1.56B | 1.16B | 1.45B | 1.50B | 5.04B | 2.38B | 4.51B | 3.66B | 4.92B | 4.42B | 3.52B | 5.34B | 5.85B | 6.39B | 5.58B |
| Long Term Debt | - | - | 7.00M | 900.66M | 749.30M | 777.40M | 806.90M | 993.96M | 3.38B | 1.78B | 1.76B | 3.77B | 4.96B | 4.96B | 4.96B | 4.96B | 4.47B | 3.72B | 3.72B |
| Total Liabilities | - | - | 719.26M | 1.58B | 2.68B | 2.57B | 2.78B | 4.02B | 6.16B | 5.14B | 5.90B | 7.28B | 9.38B | 9.86B | 10.92B | 10.57B | 10.21B | 11.48B | 11.06B |
| Current Liabilities | - | - | 558.66M | 680.76M | 1.43B | 1.40B | 1.58B | 2.63B | 2.42B | 2.95B | 3.15B | 2.37B | 3.16B | 3.53B | 4.56B | 4.18B | 4.34B | 6.57B | 5.94B |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.13M | 350.71M | 881.03M | 499.03M | 719.93M | - | - | - | 2.03B | 2.66B | 3.18B | 2.13B | 3.59B | 3.10B | 5.18B | 4.65B | 6.17B | 5.86B |
| Investing Cash Flow | 6.00M | -103.36M | -479.91M | 269.73M | -238.64M | - | - | - | -2.05B | 2.75B | -1.64B | -244.08M | 73.27M | 612.27M | -534.56M | -370.61M | -708.09M | -922.15M |
| Financing Cash Flow | -260.83M | -72.66M | 526.99M | -692.75M | -887.79M | - | - | - | -2.63B | -3.27B | -2.39B | -623.93M | -4.17B | -4.58B | -2.83B | -4.00B | -4.94B | -5.72B |
| Share Buybacks | 30.95M | 93.03M | 211.32M | 772.66M | 955.66M | 244.86M | 573.24M | 158.39M | 811.67M | 2.65B | 3.78B | 1.37B | 2.70B | 3.87B | 2.02B | 2.84B | 3.42B | 3.85B |
| Dividends Paid | - | - | - | - | - | 0 | 116.06M | 190.40M | 243.50M | 307.61M | 678.35M | 656.84M | 726.99M | 815.29M | 907.91M | 1.02B | 1.15B | 1.27B |
Ratios (Annual)
Figures in %.
| Metric | Jun 2009 | Jun 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 34.8% | 45.5% | 46.2% | 40.7% | 39.0% | 43.6% | 43.4% | 44.5% | 45.0% | 46.6% | 45.1% | 45.9% | 46.5% | 45.7% | 44.6% | 47.3% | 48.7% | 50.5% |
| Operating Margin % | -25.2% | 19.9% | 24.8% | 8.9% | 3.3% | 14.7% | 15.0% | 18.3% | 23.7% | 29.0% | 25.5% | 26.6% | 30.6% | 31.2% | 29.9% | 28.7% | 32.0% | 35.3% |
| Net Margin % | -27.1% | 16.2% | 22.4% | 6.3% | 3.2% | 13.7% | 12.5% | 15.5% | 21.2% | 21.5% | 22.7% | 22.4% | 26.7% | 26.7% | 25.9% | 25.7% | 29.1% | 31.3% |
| ROE % | -20.8% | 19.6% | 29.3% | 3.3% | 2.5% | 12.6% | 12.8% | 15.5% | 24.9% | 36.6% | 46.9% | 43.5% | 64.8% | 73.4% | 54.9% | 44.8% | 54.3% | 58.3% |
| ROCE % | - | 22.1% | 23.8% | 3.6% | 2.0% | 10.6% | 11.7% | 10.9% | 20.7% | 34.4% | 25.6% | 23.5% | 36.2% | 42.6% | 35.7% | 29.7% | 39.9% | 46.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.61% | 132.73M | $42.32B |
| 2 | Vanguard Capital Management LLC | 6.53% | 81.68M | $26.04B |
| 3 | State Street Corporation | 4.85% | 60.70M | $19.35B |
| 4 | Invesco Ltd. | 4.18% | 52.32M | $16.68B |
| 5 | JPMORGAN CHASE & CO | 3.62% | 45.32M | $14.45B |
| 6 | Vanguard Portfolio Management LLC | 2.93% | 36.64M | $11.68B |
| 7 | Geode Capital Management, LLC | 2.76% | 34.51M | $11.00B |
| 8 | FMR, LLC | 2.69% | 33.68M | $10.74B |
| 9 | Price (T.Rowe) Associates Inc | 1.97% | 24.60M | $7.84B |
| 10 | Morgan Stanley | 1.54% | 19.22M | $6.13B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LRCX
Lam Research Stock Falls As Chip-Gear Maker's Outlook Fails To Impress - Investor's Business Daily
<ol><li><a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOSGZaejNyQnBERjBSTU10QUMydnA2Rmx5MXpjZXJjYTJqLWVxYVBYTzZpRVRwa3p6cFg3WHFUNDFjXzdVa3d4NllQWlpZSU14MG1DbUhSXzlvUUQ1Ymx2Vy1EXy11ZE9GNENVSnp1dlA0SU51cVBHUGRhMW9jNkFTTHFoNWFoNG…
Lam Research: Street trims target on supply headwinds but bullish long term (LRCX:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxObi1oVlNES2lCX0RPY1h5R29FbEV3RXBET05EaGdVUXMtWVR3ZV84eDhsdmg3QU5CQXBDRWRfMWhEVnVTV1ljR0ZBTkRwZkFvQVVzLXVLMGoxRHJaSkNYeXdCMC1DQ1YwSTJmYWhWVUQzVG9pbHp0aTIyNU92NUJERHJQMTFDV3kxU1JvRX…
Lam Research slides even as Q1 results and guidance top Wall Street's forecast (LRCX:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRm1QY01fUzAtY2czWFVuYUxFYnJ4emNTZW9wUXhSVTVEdGxMRFdOV0RDa3NpUTN5MkpTWkYwME5nQmFKTXVEWGYwS3lfTXRjTXE4dDZlWUs5ZEFWNXM5aVdBaWhOcVVpUGs5VVJlT1JJQk9XZFYtNkpDOUNvS1YzeDZrNFYxVFVLYXhIUT…
AMAT vs. LRCX: Which Stock Has an Edge in the WFE Space? - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNeVZZdVVJWDBNMlUyOE5lMHJaYUQ0UHl4cC1CWWg5OFIzQ20yUVFRTTFEWGRuNGt6RzJwNDlkMkVuUnBuSHNpNnktOUFOV0g3cFNDaTFQcVBsaVN2ZWMyTjlZZ1lYUXdWalZ5WlFGZXFneGRWVU1pYUwwR1NlY21GNzhOc0NqWVhIcXlpWE…
LRCX Stock Sinks: Lam Research’s Supply Constraints May Be Capping Growth – Here’s What Analysts Say - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxOcUh2NngyeTdod2p6UVZyM25HMktpMkMwclh0LVZxQnpmeTljMlR5MFB6bTluM3o5OGJTeWp3eG1UU0N0N1QweFV1bm9sNmgwWDA4UzExbW9TNVhBSF9jY2dKRG03OEdmWGFTWmJwYnc5SmQ3UV85QnBGdFdRZmE3X2xLUXRYbkVTM3BGbk…
Lam Research Corporation Reports Financial Results for the Quarter Ended September 27, 2026 - Lam Research Newsroom
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOSWhxRmlRN1kyQVNnbzlvQXY4LTFKY2tHZ0ZaZGhZLXdIWTJUU0ZGWWRHa2VPZG1mR0xjS3pVeEpvSUVpMkVBWGRqM0xZUGo3d3JoLXJXTnNGTVBnM0Q2TDBWYW9QaGR0TkZyM2FMSVpTZUY0d2FzT0Jyc2pKTHZkNkZmREtpMnFlYnNQV0…
LRCX — Frequently Asked Questions
What is the current share price of Lam Research Corporation (LRCX)?
As of 2026-10-23 16:27 PDT, Lam Research Corporation (LRCX) trades at $230.10 on NasdaqGS. Its 52-week range is $96.50 to $432.87.
What is the market capitalisation of LRCX?
Lam Research Corporation (LRCX) has a market capitalisation of $287.93B on NasdaqGS.
What is the P/E ratio of LRCX?
LRCX trades at a trailing price-to-earnings (P/E) ratio of 39.95. The industry average P/E is 30.29. Its price-to-book (P/B) ratio is 28.91.
Does LRCX pay a dividend?
Lam Research Corporation (LRCX) currently offers a dividend yield of 0.49%.
What is the return on equity (ROE) of LRCX?
LRCX has a return on equity (ROE) of 65.07%. Its return on capital employed (ROCE) is 39.93%.
Is LRCX a good stock to buy?
This page provides a data-driven analysis of Lam Research Corporation (LRCX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.